Literature DB >> 6878188

The relationship between vasectomy and angiographically determined atherosclerosis in men.

A A Rimm, R G Hoffmann, A J Anderson, H W Gruchow, J J Barboriak.   

Abstract

Long-term prospective studies in monkeys have shown that vasectomy is associated with an increase in atherosclerotic disease. The purpose of the present investigation is to evaluate whether vasectomy in men is associated with atherosclerotic disease in the coronary arteries. In this study information was obtained on the vasectomy status in a series of 7,420 men who had previously been referred for coronary angiography because of cardiovascular symptomatology and have been followed for as long as 9 years to evaluate coronary artery bypass surgery and the natural history of the disease. It was found that 5.0% had a vasectomy prior to angiography. Two different data analysis procedures were used to determine whether the vasectomized men had a greater degree of angiographically determined coronary occlusive disease than the nonvasectomized men. Subgroups with minimal and extensive coronary artery disease were also analyzed. Results of all analyses show that the vasectomized men did not have more coronary occlusive disease. Possible patient selection biases in this study are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6878188     DOI: 10.1016/0091-7435(83)90235-9

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  3 in total

1.  Physiologic consequences and complications of vasectomy.

Authors:  M McCormack; S Lapointe
Journal:  CMAJ       Date:  1988-02-01       Impact factor: 8.262

2.  Long-term effect of vasectomy on coronary heart disease.

Authors:  E B Perrin; J S Woods; T Namekata; J Yagi; R A Bruce; V Hofer
Journal:  Am J Public Health       Date:  1984-02       Impact factor: 9.308

Review 3.  Vasectomy and cardiovascular disease risk: A systematic review and meta-analysis.

Authors:  Zhen-Lang Guo; Jing-Li Xu; Ren-Kui Lai; Shu-Sheng Wang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.